Revance Therapeutics, Inc. (NASDAQ:RVNC) Given Consensus Recommendation of “Hold” by Brokerages
Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Free Report) has received a consensus rating of “Hold” from the eight brokerages that are covering the stock, MarketBeat reports. Seven research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 1 year price objective among brokers […]
Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Free Report) has received a consensus rating of “Hold” from the eight brokerages that are covering the stock, MarketBeat reports. Seven research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 1 year price objective among brokers […]
